Back to Results

Embolization of the Middle Meningeal Artery with ONYX(TM) Liquid Embolic System in the Treatment of Subactue and Chronic Subdural Hematoma (EMBOLISE)

Study

Is this Study for You?

Let's Get Started!

Description

The purpose of this study is to evaluate the safety (short and long term side effects) and effectiveness (how well it helps) of Onyx Liquid Embolic System(LES) (study device) embolization of the middle meningeal artery when used in addition to the standard treatment that is used to treat a subdural hematoma.

Details
Age

Adult

Eligibility

Adult with chronic or sub-chronic subdural hematoma

Detailed Eligibility: Adult with chronic or sub-chronic subdural hematoma

Phase

Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.

Type of Study

Treatment

Location

University of Colorado Hospital

Principal Investigator
Christoper Roark

Christoper Roark

Study ID

Protocol Number: 20-1390

More information available at ClinicalTrials.gov: NCT04402632

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers